US Patent Issued to Biohaven Therapeutics on July 7 for "Bifunctional degraders of galactose-deficient immunoglobulins" (Connecticut, Massachusetts, North Carolina Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,111, issued on July 7, was assigned to Biohaven Therapeutics Ltd. (Tortola, British Virgin Islands).

"Bifunctional degraders of galactose-deficient immunoglobulins" was invented by Gene M. Dubowchik (Killingworth, Conn.), Ada Vaill (Salem, Conn.), Reese M. Caldwell (Cambridge, Mass.), Brian M. Linhares (Bedford, Mass.), David K. Leahy (Marblehead, Mass.), James Bryson (Asheville, N.C.) and Lawrence R. Marcin (Bethany, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition of matter including a deglycosylated IgA-binding moiety, a cellular receptor-binding moiety that binds to hepatocytes or other degrading cells through asialoglycoprotein...